Stay updated with breaking news from Nasdaq Vbiv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a report issued on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Trading Up 1.3 % VBIV traded up $0.01 during trading on Friday, hitting $0.59. The company had a trading volume of 165,340 shares, […]
StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Performance Shares of NASDAQ VBIV opened at $0.56 on Friday. VBI Vaccines has a 52-week low of $0.45 and […]
StockNews.com began coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a report published on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Down 4.2 % Shares of VBIV opened at $0.57 on Friday. The company has a market cap of $16.32 million, a PE ratio […]
VBI Vaccines Inc. (NASDAQ:VBIV – Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 709,500 shares, a growth of 145.4% from the March 31st total of 289,100 shares. Based on an average daily volume of 445,600 shares, […]
Stock analysts at StockNews.com began coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Performance Shares of VBIV stock opened at $0.63 on Thursday. VBI Vaccines has a 52-week low […]